The features of autism are often subtle and difficult to define.
But roughly one-third of individuals with the disorder have one symptom that’s almost impossible to miss: seizures.
Posted in
Epilepsy,
Medication Issues,
ResearchTags:
anti-epileptic drugs,
autism,
cognitive,
development regression,
EEG,
Epilepsy,
gene mutation,
motor and language delays,
neurological disorder,
seizures,
social and emotional problems,
treatment resistant epilepsy
Severe Myoclonic Epilepsy of Infancy was first described by Dravet in 1978.
In 1992, Dravet and colleagues found at least 172 published cases. Since then there have been numerous new cases.
Dravet Syndrome, also known as Severe Myoclonic Epilepsy of Infancy (SMEI), is a rare and catastrophic form of intractable epilepsy that begins in infancy.
Posted in
Epilepsy,
Medication Issues,
ResearchTags:
anticonvulsant drugs,
clinical trials,
Dravet Syndrome,
gene mutation,
intractable seizures,
Ketogenic Diet,
no brain biopsy needed,
Severe Myoclonic Epilepsy of Infancy (SMEI),
stem cell based